# Aktis Oncology (AKTS): value investors who own it

1 value investor held Aktis Oncology in their Q3 2026 13F, led by Polen Capital Management. See who bought, sold and how ownership has changed by quarter.

## 13F holders

| Manager | Portfolio | Value | Change | Quarters held |
| --- | --- | --- | --- | --- |
| Polen Capital Management | 0.0% | $2.0m | New | 1 |

## Directors buying and selling (Form 4, last 12 months)

| Date | Who | Role | Bought or sold | Shares | Value |
| --- | --- | --- | --- | --- | --- |
| 2026-09-23 | Czibere Akos | Chief Medical Officer | Sold | 7401 | $156k |
| 2026-09-23 | Czibere Akos | Chief Medical Officer | Sold | 5099 | $103k |
| 2026-07-20 | Herrmann Ken | Director | Sold | 3506 | $86k |
| 2026-07-20 | Herrmann Ken | Director | Sold | 1350 | $33k |
| 2026-07-17 | Herrmann Ken | Director | Sold | 3065 | $77k |

Source: SEC filings, via moatshark (https://www.moatshark.com/s/akts). Values traded and returns are estimates. Not investment advice. Built 2026-10-21.